» Authors » Amir Shamshirian

Amir Shamshirian

Explore the profile of Amir Shamshirian including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 20
Citations 1773
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Shojaei M, Shamshirian A, Monkman J, Grice L, Tran M, Tan C, et al.
Front Immunol . 2023 Jan; 13:1060438. PMID: 36685600
Purpose: Robust biomarkers that predict disease outcomes amongst COVID-19 patients are necessary for both patient triage and resource prioritisation. Numerous candidate biomarkers have been proposed for COVID-19. However, at present,...
2.
Azizi S, Shamshirian A, Alizadeh-Navaei R, Jafarpour H, Asemi Z, Tamtaji O, et al.
Galen Med J . 2021 Sep; 8:e1472. PMID: 34466514
Methylenetetrahydrofolate reductase () is an enzyme that plays a crucial role as a methyl-group donor in demethylation of homocysteine. The aim of this systematic review and meta-analysis was to study...
3.
Mousavi S, Heydari K, Mehravaran H, Saeedi M, Alizadeh-Navaei R, Hedayatizadeh-Omran A, et al.
J Med Virol . 2021 Aug; 94(1):263-271. PMID: 34460132
This trial aims to evaluate the effectiveness of adding melatonin to the treatment protocol of hospitalized coronavirus disease 2019 (COVID-19) patients. This was an open-label, randomized controlled clinical trial in...
4.
Ghasemian R, Shamshirian A, Heydari K, Malekan M, Alizadeh-Navaei R, Ebrahimzadeh M, et al.
Int J Clin Pract . 2021 Jul; 75(11):e14675. PMID: 34322971
Background: Evidence recommends that vitamin D might be a crucial supportive agent for the immune system, mainly in cytokine response regulation against COVID-19. Hence, we carried out a systematic review...
5.
Mohammadi H, Shamshirian A, Eslami S, Shamshirian D, Ebrahimzadeh M
Biomed Res Int . 2020 Dec; 2020:2624734. PMID: 33381544
Mg is an important cation in our body. It is an essential cofactor for many enzymes. Despite many works, nothing is known about the protective effects of MgSO against hypoxia-induced...
6.
Roozbeh F, Saeedi M, Alizadeh-Navaei R, Hedayatizadeh-Omran A, Merat S, Wentzel H, et al.
J Antimicrob Chemother . 2020 Dec; 76(3):753-757. PMID: 33338232
Introduction: Effective treatments are urgently needed to tackle the novel coronavirus disease 2019 (COVID-19). This trial aims to evaluate sofosbuvir and daclatasvir versus standard care for outpatients with mild COVID-19...
7.
Hosseinzadeh M, Shamshirian A, Ebrahimzadeh M
Int J Clin Pract . 2020 Dec; 75(6):e13943. PMID: 33332726
Background: The preliminary report of the RECOVERY large randomised controlled trial indicated a promising survival effect for dexamethasone therapy of coronavirus disease 2019 (COVID-19). This study aimed to investigate the...
8.
Shamshirian A, Hessami A, Heydari K, Navaei R, Ebrahimzadeh M, Yip G, et al.
Ann Acad Med Singap . 2020 Dec; 49(10):789-800. PMID: 33283842
Objective: A systematic review and meta-analysis was carried out to examine the role of hydroxychloroquine (HCQ) in the treatment of COVID-19. Methods: We performed a systematic search in PubMed, Scopus,...
9.
Hessami A, Shamshirian A, Heydari K, Pourali F, Alizadeh-Navaei R, Moosazadeh M, et al.
Am J Emerg Med . 2020 Dec; 46:382-391. PMID: 33268238
Background: High rate of cardiovascular disease (CVD) have been reported among patients with novel coronavirus disease (COVID-19). Meanwhile there were controversies among different studies about CVD burden in COVID-19 patients....
10.
Shamshirian A, Aref A, Yip G, Warkiani M, Heydari K, Razavi Bazaz S, et al.
BMC Cancer . 2020 Nov; 20(1):1049. PMID: 33129287
Background: Measurement of serum human epidermal growth factor receptor-2 (HER-2/neu) levels might play an essential role as a diagnostic/screening marker for the early selection of therapeutic approaches and predict prognosis...